Cargando…
2450. Antibiotic Treatment for Carbapenem-Resistant Enterobacteriaceae (CRE) and Outcomes in Veterans With Spinal Cord Injury/Disorder (SCI/D)
BACKGROUND: A total of 282,000 people (17% veterans) in the United States have SCI/D. Infection is a significant source of morbidity and the leading cause of death in this population. Due to frequent healthcare contact and antibiotic use, SCI/D is associated with high risk of multidrug-resistant inf...
Autores principales: | Little, Erica K, Patel, Ursula C, Suda, Katie J, Fitzpatrick, Margaret, Evans, Charlesnika T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255492/ http://dx.doi.org/10.1093/ofid/ofy210.2103 |
Ejemplares similares
-
1591. Antibiotic Utilization Trends in Veterans Affairs (VA) Patients with Carbapenem Resistant Enterobacteriaceae (CRE) Infections
por: Traversa, Alfredo, et al.
Publicado: (2020) -
Evaluation of carbapenem-resistant Enterobacteriaceae (CRE) guideline implementation in the Veterans Affairs Medical Centers using the consolidated framework for implementation research
por: Goedken, Cassie Cunningham, et al.
Publicado: (2021) -
843. Increased Carbapenemase Testing Following Implementation of VA Guidelines for Carbapenem-Resistant Enterobacteriaceae (CRE)
por: Fitzpatrick, Margaret A, et al.
Publicado: (2020) -
525. Evaluation of Implementation of Guidelines for Carbapenem-resistant Enterobacteriaceae (CRE) Prevention Using the Consolidated Framework for Implementation Research (CFIR)
por: Goedken, Cassie, et al.
Publicado: (2019) -
Increased carbapenemase testing following implementation of national
VA guidelines for carbapenem-resistant Enterobacterales (CRE)
por: Fitzpatrick, Margaret A., et al.
Publicado: (2022)